Lupin Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "Lupin Launches Bosentan Tablets for Oral Suspension in the United Stateswith 180-Day Exclusivity".
Lupin Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "Lupin Launches Bosentan Tablets for Oral Suspension in the United Stateswith 180-Day Exclusivity".